Impact of the Affordable Care Act on Insurance Status of Patients Newly Diagnosed With Kaposi Sarcoma
Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 2
Abstract
Background: The Affordable Care Act (ACA) role in changing the insurance composition of patients diagnosed with many dermatological conditions, such as Kaposi Sarcoma (KS), has not been assessed. Methods: The Surveillance, Epidemiology and End Results (SEER) Program, which captures cancer data from nearly 40% of cases in the US was used to extract cases. Cases were subgrouped by Medicaid expansion and non-expansion states. Standard mean differences were used as the statistical measure with P-value <0.05 used for statistical significance. Results: 2,465 patients met the inclusion criteria. In patients newly diagnosed with Kaposi sarcoma nationally before and after ACA implementation, the analysis showed there was no significant difference in the percentage of uninsured patients, Medicaid-insured patients, or privately insured patients. Pre- and post-ACA sub-analysis of patients newly diagnosed with Kaposi sarcoma in states that expanded Medicaid showed: (1) significant decrease in the percentage of uninsured patients (-5.81% difference, 95% CI -9.58% to -2.04%, P <.05); (2) significant increase in the percentage of Medicaid-insured patients (+9.36% difference, 95% CI +0.35% to +18.37%, P <.05) and (3) no significant difference in the percent of privately insured patients (-3.54% difference, 95% CI -13.74% to +6.64%). Sub-analysis in non-expansion states showed no difference between the insurance subtypes. Conclusion: Medicaid expansion played the largest role in reducing the percentage of uninsured patients newly diagnosed with KS. In states without Medicaid expansion, it is important that public health forces ensure adequate access to medications with services like the Ryan White HIV/AIDS Program.
Authors and Affiliations
Vignesh Ramachandran, Esha Hansoti
Keywords
Related Articles
- EP ID EP717152
- DOI https://doi.org/10.46889/JDR.2023.4204
- Views 28
- Downloads 0
Nail Involvement in Pemphigus: Brief Report
Background: The objective of our study is to describe the different nail involvement at the beginning of the disease according to the type of pemphigus and according to the severity of the pemphigus. Material and meth...
JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
Baricitinib, a JAK1/2 inhibitor, has been expanding its role as a therapeutic agent with recent FDA approval for dermatologic use with alopecia areata. Clinical trials are underway for further use of baricitinib for seve...
Successful Control of Some Challenging Cases in Late Adult and Elderly Onset Atopic Dermatitis with Dupilumab Injection in Kuwaiti Patients: A Prospective Pilot Study
Atopic Dermatitis is severely itchy skin disease with chronic prolonged course and relapsing flares, which was considered mainly infantile or childhood in onset for a long time. Atopic Dermatitis is not any more a pediat...
In-vivo Studies of Cosmetics with Ultraviolet Light Filter and Synergistic Antioxidant Care
The natural process of skin melanogenesis is an evolutionarily valuable mechanism that protects the human body against excessive exposure to solar radiation. Cosmetics with a filter are a very important invention of the...
Synergistic antiaging and Dermal Restorative Effects of an Oral Bioactive Procollagen and Astaxanthin Supplement with A Topical Retinyl Palmitate, Vitamin C, Hyaluronic Acid and Alpha Hidroxy Acid Based Regimen
Aging is a natural process undergone by every organism, with progressive changes that lead to an impairment of many biological processes. The human skin ages through several mechanisms which may cause changes to the mo...